Xianwei Mo

机构：Guangxi Medical University, Macao Polytechnic University · ORCID：0000-0002-4245-2836

发表论文 87 篇 · 总被引 1401 次 · h-index 22

代表论文

• Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial (2022 · Annals of Surgery · 被引 87)
• Comprehensive multi-omics analysis of the m7G in pan-cancer from the perspective of predictive, preventive, and personalized medicine (2022 · The EPMA Journal · 被引 30)
• Identification of HSP90B1 in pan-cancer hallmarks to aid development of a potential therapeutic target (2024 · Molecular Cancer · 被引 25)
• Neoadjuvant treatment of IBI310 plus sintilimab in locally advanced MSI-H/dMMR colon cancer: A randomized phase 1b study (2025 · Cancer Cell · 被引 24)
• Identification of KRAS mutation-associated gut microbiota in colorectal cancer and construction of predictive machine learning model (2024 · Microbiology Spectrum · 被引 22)
• Neoadjuvant treatment of IBI310 (anti-CTLA-4 antibody) plus sintilimab (anti-PD-1 antibody) in patients with microsatellite instability-high/mismatch repair-deficient colorectal cancer: Results from a randomized, open-labeled, phase Ib study. (2024 · Journal of Clinical Oncology · 被引 19)